{"gene":"TG_311100","gene_symbol":"BFD2","run_date":"2026-09-08T15:15:13","timeline":{"discoveries":[{"year":2023,"finding":"BFD2 is a cytosolic RNA-binding protein of the CCCH-type zinc-finger family that is transcriptionally activated by BFD1. BFD2 interacts with the BFD1 transcript under stress conditions, and deletion of BFD2 reduces BFD1 protein levels without affecting BFD1 mRNA abundance, indicating BFD2 acts as a post-transcriptional regulator of BFD1 translation. This establishes a positive feedback loop in which BFD1 drives BFD2 transcription and BFD2 promotes BFD1 translation, enforcing the chronic-stage gene-expression programme.","method":"Genetic knockout (ΔBFD2), RNA binding assay (BFD2 co-immunoprecipitation with BFD1 mRNA under stress), western blot and mRNA quantification to separate protein vs mRNA levels, in vitro and in vivo differentiation assays","journal":"Nature microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal genetic and biochemical approaches (KO phenotype, RNA-binding interaction, protein vs mRNA dissociation), single lab but multiple orthogonal methods with clear mechanistic conclusion","pmids":["37081202"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"finding":"Parasites lacking BFD2 fail to induce BFD1 protein and are consequently unable to fully differentiate into bradyzoites either in culture or in mice, demonstrating BFD2 is required for stage conversion.","method":"Genetic knockout (ΔBFD2), in vitro differentiation assays, in vivo mouse infection with cyst burden assessment","journal":"Nature microbiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean KO with defined cellular phenotype confirmed both in vitro and in vivo, multiple readouts","pmids":["37081202"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2024,"finding":"BFD2/ROCY1 is necessary for cap-independent translation of BFD1 through direct binding to the 5'-leader of BFD1 mRNA. This was demonstrated by showing that translational control of BFD1 persists when ribosome assembly near the 5'-cap is blocked (by a 5'-proximal stem-loop insertion or knockdown of cap-binding protein eIF4E1), and that BFD2 knockdown abolishes this cap-independent translation.","method":"Biochemical and molecular approaches: 5'-leader reporter assays, 5'-proximal stem-loop insertion, eIF4E1 knockdown, BFD2 knockdown, cap-independent translation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal biochemical approaches (reporter assays, cap-impairment constructs, RBP knockdown) in a single study establishing the mechanism","pmids":["39542243"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2024,"finding":"Translation initiation factor eIF1.2 is required upstream of BFD2 for stress-induced differentiation; Δeif1.2 parasites fail to upregulate BFD1 and BFD2 during stress, and forced expression of BFD2 (or BFD1) significantly restores differentiation in Δeif1.2 parasites, placing BFD2 downstream of eIF1.2 in the differentiation pathway.","method":"Genetic ablation (Δeif1.2), RNA sequencing, ribosome profiling, forced overexpression of BFD2, in vitro and in vivo cyst formation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis established by KO + ribosome profiling + rescue experiment; replicated in preprint and peer-reviewed publication","pmids":["38782906","37961607"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"finding":"ROCY1 (the same protein as BFD2) encodes an RNA-binding protein whose RNA-binding domains are required to mediate bradyzoite development; it has a preference for 3' regulatory regions of hundreds of T. gondii transcripts, and is sufficient for bradyzoite formation in vitro and in vivo.","method":"Genetic knockout (ΔROCY1), domain mutation of RNA-binding domains, RIP-seq or binding preference assays, in vitro and in vivo bradyzoite/cyst formation assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO phenotype with domain mutagenesis (RNA-binding domain requirement) and transcriptome-wide binding data across multiple readouts","pmids":["37770433"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"finding":"BFD2 knockout (ME49Δbfd2) reduces parasite proliferation and plaque formation in vitro, and in vivo Δbfd2 parasites induce reduced inflammatory cytokine expression (IL-1β, IFN-γ, TNF-α) in infected BV2 cells and reduce brain inflammation and neuronal apoptosis specifically during acute infection, linking BFD2 to regulation of acute-stage host-parasite interactions.","method":"CRISPR/Cas9-mediated BFD2 knockout, RNA sequencing of infected BV2 cells, western blot, qPCR, ELISA, in vivo mouse infection with behavioural testing (elevated plus maze, open field test)","journal":"PLoS neglected tropical diseases","confidence":"Medium","confidence_rationale":"Tier 2–3 / Weak — clean CRISPR KO with multiple readouts but single lab; the mechanistic link between BFD2's known RNA-binding function and the inflammatory phenotype is not directly resolved","pmids":["40906736"],"is_preprint":false,"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]}],"current_model":"BFD2 is a cytosolic CCCH-type zinc-finger RNA-binding protein that is transcriptionally induced by BFD1 and in turn promotes BFD1 protein synthesis by binding the 5'-leader of BFD1 mRNA to drive cap-independent translation under stress, forming a positive feedback loop that initiates and commits Toxoplasma gondii to chronic bradyzoite differentiation; this pathway requires upstream translation initiation factor eIF1.2, and BFD2's RNA-binding domains are essential for its activity across hundreds of target transcripts enriched at 3' regulatory regions."},"narrative":{"mechanistic_narrative":"BFD2 (also called ROCY1) is a cytosolic CCCH-type zinc-finger RNA-binding protein that acts as the master post-transcriptional switch committing Toxoplasma gondii to chronic bradyzoite differentiation [PMID:37081202, PMID:37770433]. It is transcriptionally induced by the differentiation regulator BFD1 and in turn binds the BFD1 transcript to promote BFD1 protein accumulation without altering BFD1 mRNA levels, establishing a positive feedback loop that enforces the chronic-stage gene-expression programme [PMID:37081202]. Mechanistically, BFD2 drives cap-independent translation of BFD1 by directly binding the 5'-leader of BFD1 mRNA, sustaining BFD1 synthesis when 5'-cap-dependent initiation is impaired [PMID:39542243]. This activity requires BFD2's RNA-binding domains, which mediate binding across hundreds of transcripts with a preference for 3' regulatory regions, and is sufficient to drive bradyzoite formation in vitro and in vivo [PMID:37770433]. BFD2 operates downstream of the translation initiation factor eIF1.2 in the stress-induced differentiation pathway, and forced BFD2 expression restores differentiation in eIF1.2-deficient parasites [PMID:38782906, PMID:37961607]. Beyond its role in stage conversion, BFD2 also modulates acute-stage host-parasite interactions, with ME49Δbfd2 parasites showing reduced proliferation and dampened host inflammatory responses [PMID:40906736].","teleology":[{"year":2023,"claim":"Established that BFD1's differentiation programme is enforced not only transcriptionally but through a post-transcriptional feedback partner, identifying BFD2 as a BFD1-induced RNA-binding protein that reciprocally promotes BFD1 protein synthesis.","evidence":"ΔBFD2 knockout with RNA co-immunoprecipitation of BFD1 mRNA, and dissociation of BFD1 protein from mRNA levels by western blot and mRNA quantification, in T. gondii","pmids":["37081202"],"confidence":"High","gaps":["Molecular basis of RNA sequence/structure recognition on BFD1 mRNA not defined","Whether other partners contribute to the feedback loop unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"claim":"Demonstrated that BFD2 is functionally required for stage conversion, showing that loss of BFD2 blocks bradyzoite differentiation in culture and in mice.","evidence":"ΔBFD2 in vitro differentiation assays and in vivo mouse infection with cyst burden assessment","pmids":["37081202"],"confidence":"High","gaps":["Does not resolve which BFD2 target transcripts beyond BFD1 are needed for full differentiation"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2023,"claim":"Defined BFD2/ROCY1's transcriptome-wide binding behavior and showed its RNA-binding domains are mechanistically essential and sufficient to drive bradyzoite development.","evidence":"ΔROCY1 knockout with RNA-binding domain mutagenesis and binding-preference/RIP-seq analysis plus in vitro and in vivo cyst formation assays in T. gondii","pmids":["37770433"],"confidence":"High","gaps":["Functional consequence of binding at 3' regulatory regions for most targets unclear","Distinction between direct and indirect targets not fully resolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2024,"claim":"Resolved the translational mechanism by showing BFD2 drives cap-independent translation of BFD1 via direct 5'-leader binding, explaining how BFD1 synthesis persists under stress.","evidence":"5'-leader reporter assays, 5'-proximal stem-loop insertion, eIF4E1 knockdown, and BFD2 knockdown cap-independent translation assays in T. gondii","pmids":["39542243"],"confidence":"High","gaps":["Identity of the ribosome recruitment machinery used in the cap-independent mode not defined","Whether BFD2 uses the same mechanism on its other targets unknown"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2024,"claim":"Placed BFD2 in a defined genetic pathway by establishing translation initiation factor eIF1.2 as an upstream requirement, with BFD2 acting downstream.","evidence":"Δeif1.2 knockout with RNA sequencing, ribosome profiling, and rescue by forced BFD2 (or BFD1) expression in T. gondii","pmids":["38782906","37961607"],"confidence":"High","gaps":["Direct biochemical link between eIF1.2 and BFD2 translation not established","How stress signals feed into eIF1.2 unresolved"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]},{"year":2025,"claim":"Extended BFD2's relevance beyond differentiation, linking it to acute-stage proliferation and to modulation of host inflammatory responses during infection.","evidence":"CRISPR/Cas9 ME49Δbfd2 with plaque assays, RNA-seq of infected BV2 cells, ELISA cytokine profiling, and in vivo mouse infection with behavioural testing","pmids":["40906736"],"confidence":"Medium","gaps":["Mechanistic link between BFD2's RNA-binding function and the inflammatory phenotype not resolved","Single-lab findings in ME49 strain only","Whether the acute-stage effect is direct or a consequence of altered differentiation unclear"],"attribution":[{"species":"Toxoplasma gondii","strain":"ME49"}]},{"year":null,"claim":"How BFD2 achieves selective recognition of its target transcripts and mechanistically integrates 3'-region binding with 5'-leader-driven cap-independent translation across its regulon remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of BFD2-RNA recognition","Full target regulon and functional consequences per target uncharacterized","Connection between 3' binding preference and translational activation unexplained"],"attribution":[{"species":"Toxoplasma gondii","strain":""}]}],"mechanism_profile":{"molecular_activity":[],"localization":[],"pathway":[],"complexes":[],"partners":["BFD1 (TRANSCRIPTIONAL INDUCER OF BFD2 AND TRANSLATIONAL TARGET VIA 5'-LEADER BINDING)","EIF1.2 (TRANSLATION INITIATION FACTOR ACTING UPSTREAM OF BFD2)","EIF4E1 (CAP-BINDING PROTEIN; DISPENSABLE FOR BFD2-DRIVEN CAP-INDEPENDENT TRANSLATION)"],"other_free_text":["BFD2/ROCY1 forms a positive feedback loop with BFD1: BFD1 drives BFD2 transcription, BFD2 promotes BFD1 protein synthesis.","Binds hundreds of T. gondii transcripts with a preference for 3' regulatory regions; RNA-binding domains are essential for activity.","Drives cap-independent translation of BFD1 via direct binding to the BFD1 5'-leader.","ME49Δbfd2 shows reduced proliferation and dampened host inflammatory cytokine induction during acute infection."]},"strain_conflicts":[]},"prefetch_data":{},"corpus_meta":[{"pmid":"37081202","id":"PMC_37081202","title":"A positive feedback loop controls Toxoplasma chronic differentiation.","date":"2023","source":"Nature microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/37081202","citation_count":41,"is_preprint":false},{"pmid":"37770433","id":"PMC_37770433","title":"A transcriptional network required for bradyzoite development in Toxoplasma gondii is dispensable for recrudescent disease.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37770433","citation_count":22,"is_preprint":false},{"pmid":"39150246","id":"PMC_39150246","title":"Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii.","date":"2024","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/39150246","citation_count":11,"is_preprint":false},{"pmid":"38782906","id":"PMC_38782906","title":"Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38782906","citation_count":9,"is_preprint":false},{"pmid":"39542243","id":"PMC_39542243","title":"Cap-independent translation directs stress-induced differentiation of the protozoan parasite Toxoplasma gondii.","date":"2024","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/39542243","citation_count":5,"is_preprint":false},{"pmid":"38464000","id":"PMC_38464000","title":"Constitutive upregulation of transcription factors underlies permissive bradyzoite differentiation in a natural isolate of Toxoplasma gondii.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38464000","citation_count":2,"is_preprint":false},{"pmid":"37961607","id":"PMC_37961607","title":"Translation initiation factor eIF1.2 promotes Toxoplasma stage conversion by regulating levels of key differentiation factors.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/37961607","citation_count":1,"is_preprint":false},{"pmid":"40906736","id":"PMC_40906736","title":"BFD2 mediates inflammation, apoptosis, and pre-anxiety-like behaviors induced by acute Toxoplasma gondii infection.","date":"2025","source":"PLoS neglected tropical diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40906736","citation_count":0,"is_preprint":false},{"pmid":"41925158","id":"PMC_41925158","title":"Translational control of Toxoplasma gondii differentiation.","date":"2026","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/41925158","citation_count":0,"is_preprint":false},{"pmid":"39345546","id":"PMC_39345546","title":"Cap-independent translation directs stress-induced differentiation of the protozoan parasite Toxoplasma gondii.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39345546","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7236,"output_tokens":1929,"usd":0.025322,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":7303,"output_tokens":3315,"usd":0.059695,"stage2_stop_reason":"end_turn"},"total_usd":0.085017,"stage1_batch_id":"msgbatch_01S6GjoYQm8LTPUsdhASdqag","stage2_batch_id":"msgbatch_01VX63RTMdBJqsG6gQMqoCjz","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2023,\n      \"finding\": \"BFD2 is a cytosolic RNA-binding protein of the CCCH-type zinc-finger family that is transcriptionally activated by BFD1. BFD2 interacts with the BFD1 transcript under stress conditions, and deletion of BFD2 reduces BFD1 protein levels without affecting BFD1 mRNA abundance, indicating BFD2 acts as a post-transcriptional regulator of BFD1 translation. This establishes a positive feedback loop in which BFD1 drives BFD2 transcription and BFD2 promotes BFD1 translation, enforcing the chronic-stage gene-expression programme.\",\n      \"method\": \"Genetic knockout (ΔBFD2), RNA binding assay (BFD2 co-immunoprecipitation with BFD1 mRNA under stress), western blot and mRNA quantification to separate protein vs mRNA levels, in vitro and in vivo differentiation assays\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal genetic and biochemical approaches (KO phenotype, RNA-binding interaction, protein vs mRNA dissociation), single lab but multiple orthogonal methods with clear mechanistic conclusion\",\n      \"pmids\": [\"37081202\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Parasites lacking BFD2 fail to induce BFD1 protein and are consequently unable to fully differentiate into bradyzoites either in culture or in mice, demonstrating BFD2 is required for stage conversion.\",\n      \"method\": \"Genetic knockout (ΔBFD2), in vitro differentiation assays, in vivo mouse infection with cyst burden assessment\",\n      \"journal\": \"Nature microbiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean KO with defined cellular phenotype confirmed both in vitro and in vivo, multiple readouts\",\n      \"pmids\": [\"37081202\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BFD2/ROCY1 is necessary for cap-independent translation of BFD1 through direct binding to the 5'-leader of BFD1 mRNA. This was demonstrated by showing that translational control of BFD1 persists when ribosome assembly near the 5'-cap is blocked (by a 5'-proximal stem-loop insertion or knockdown of cap-binding protein eIF4E1), and that BFD2 knockdown abolishes this cap-independent translation.\",\n      \"method\": \"Biochemical and molecular approaches: 5'-leader reporter assays, 5'-proximal stem-loop insertion, eIF4E1 knockdown, BFD2 knockdown, cap-independent translation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal biochemical approaches (reporter assays, cap-impairment constructs, RBP knockdown) in a single study establishing the mechanism\",\n      \"pmids\": [\"39542243\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Translation initiation factor eIF1.2 is required upstream of BFD2 for stress-induced differentiation; Δeif1.2 parasites fail to upregulate BFD1 and BFD2 during stress, and forced expression of BFD2 (or BFD1) significantly restores differentiation in Δeif1.2 parasites, placing BFD2 downstream of eIF1.2 in the differentiation pathway.\",\n      \"method\": \"Genetic ablation (Δeif1.2), RNA sequencing, ribosome profiling, forced overexpression of BFD2, in vitro and in vivo cyst formation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis established by KO + ribosome profiling + rescue experiment; replicated in preprint and peer-reviewed publication\",\n      \"pmids\": [\"38782906\", \"37961607\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ROCY1 (the same protein as BFD2) encodes an RNA-binding protein whose RNA-binding domains are required to mediate bradyzoite development; it has a preference for 3' regulatory regions of hundreds of T. gondii transcripts, and is sufficient for bradyzoite formation in vitro and in vivo.\",\n      \"method\": \"Genetic knockout (ΔROCY1), domain mutation of RNA-binding domains, RIP-seq or binding preference assays, in vitro and in vivo bradyzoite/cyst formation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO phenotype with domain mutagenesis (RNA-binding domain requirement) and transcriptome-wide binding data across multiple readouts\",\n      \"pmids\": [\"37770433\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"BFD2 knockout (ME49Δbfd2) reduces parasite proliferation and plaque formation in vitro, and in vivo Δbfd2 parasites induce reduced inflammatory cytokine expression (IL-1β, IFN-γ, TNF-α) in infected BV2 cells and reduce brain inflammation and neuronal apoptosis specifically during acute infection, linking BFD2 to regulation of acute-stage host-parasite interactions.\",\n      \"method\": \"CRISPR/Cas9-mediated BFD2 knockout, RNA sequencing of infected BV2 cells, western blot, qPCR, ELISA, in vivo mouse infection with behavioural testing (elevated plus maze, open field test)\",\n      \"journal\": \"PLoS neglected tropical diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Weak — clean CRISPR KO with multiple readouts but single lab; the mechanistic link between BFD2's known RNA-binding function and the inflammatory phenotype is not directly resolved\",\n      \"pmids\": [\"40906736\"],\n      \"is_preprint\": false,\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    }\n  ],\n  \"current_model\": \"BFD2 is a cytosolic CCCH-type zinc-finger RNA-binding protein that is transcriptionally induced by BFD1 and in turn promotes BFD1 protein synthesis by binding the 5'-leader of BFD1 mRNA to drive cap-independent translation under stress, forming a positive feedback loop that initiates and commits Toxoplasma gondii to chronic bradyzoite differentiation; this pathway requires upstream translation initiation factor eIF1.2, and BFD2's RNA-binding domains are essential for its activity across hundreds of target transcripts enriched at 3' regulatory regions.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BFD2 (also called ROCY1) is a cytosolic CCCH-type zinc-finger RNA-binding protein that acts as the master post-transcriptional switch committing Toxoplasma gondii to chronic bradyzoite differentiation [#0, #4]. It is transcriptionally induced by the differentiation regulator BFD1 and in turn binds the BFD1 transcript to promote BFD1 protein accumulation without altering BFD1 mRNA levels, establishing a positive feedback loop that enforces the chronic-stage gene-expression programme [#0]. Mechanistically, BFD2 drives cap-independent translation of BFD1 by directly binding the 5'-leader of BFD1 mRNA, sustaining BFD1 synthesis when 5'-cap-dependent initiation is impaired [#2]. This activity requires BFD2's RNA-binding domains, which mediate binding across hundreds of transcripts with a preference for 3' regulatory regions, and is sufficient to drive bradyzoite formation in vitro and in vivo [#4]. BFD2 operates downstream of the translation initiation factor eIF1.2 in the stress-induced differentiation pathway, and forced BFD2 expression restores differentiation in eIF1.2-deficient parasites [#3]. Beyond its role in stage conversion, BFD2 also modulates acute-stage host-parasite interactions, with ME49\\u0394bfd2 parasites showing reduced proliferation and dampened host inflammatory responses [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2023,\n      \"claim\": \"Established that BFD1's differentiation programme is enforced not only transcriptionally but through a post-transcriptional feedback partner, identifying BFD2 as a BFD1-induced RNA-binding protein that reciprocally promotes BFD1 protein synthesis.\",\n      \"evidence\": \"\\u0394BFD2 knockout with RNA co-immunoprecipitation of BFD1 mRNA, and dissociation of BFD1 protein from mRNA levels by western blot and mRNA quantification, in T. gondii\",\n      \"pmids\": [\"37081202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of RNA sequence/structure recognition on BFD1 mRNA not defined\", \"Whether other partners contribute to the feedback loop unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrated that BFD2 is functionally required for stage conversion, showing that loss of BFD2 blocks bradyzoite differentiation in culture and in mice.\",\n      \"evidence\": \"\\u0394BFD2 in vitro differentiation assays and in vivo mouse infection with cyst burden assessment\",\n      \"pmids\": [\"37081202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Does not resolve which BFD2 target transcripts beyond BFD1 are needed for full differentiation\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined BFD2/ROCY1's transcriptome-wide binding behavior and showed its RNA-binding domains are mechanistically essential and sufficient to drive bradyzoite development.\",\n      \"evidence\": \"\\u0394ROCY1 knockout with RNA-binding domain mutagenesis and binding-preference/RIP-seq analysis plus in vitro and in vivo cyst formation assays in T. gondii\",\n      \"pmids\": [\"37770433\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of binding at 3' regulatory regions for most targets unclear\", \"Distinction between direct and indirect targets not fully resolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Resolved the translational mechanism by showing BFD2 drives cap-independent translation of BFD1 via direct 5'-leader binding, explaining how BFD1 synthesis persists under stress.\",\n      \"evidence\": \"5'-leader reporter assays, 5'-proximal stem-loop insertion, eIF4E1 knockdown, and BFD2 knockdown cap-independent translation assays in T. gondii\",\n      \"pmids\": [\"39542243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the ribosome recruitment machinery used in the cap-independent mode not defined\", \"Whether BFD2 uses the same mechanism on its other targets unknown\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Placed BFD2 in a defined genetic pathway by establishing translation initiation factor eIF1.2 as an upstream requirement, with BFD2 acting downstream.\",\n      \"evidence\": \"\\u0394eif1.2 knockout with RNA sequencing, ribosome profiling, and rescue by forced BFD2 (or BFD1) expression in T. gondii\",\n      \"pmids\": [\"38782906\", \"37961607\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct biochemical link between eIF1.2 and BFD2 translation not established\", \"How stress signals feed into eIF1.2 unresolved\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Extended BFD2's relevance beyond differentiation, linking it to acute-stage proliferation and to modulation of host inflammatory responses during infection.\",\n      \"evidence\": \"CRISPR/Cas9 ME49\\u0394bfd2 with plaque assays, RNA-seq of infected BV2 cells, ELISA cytokine profiling, and in vivo mouse infection with behavioural testing\",\n      \"pmids\": [\"40906736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanistic link between BFD2's RNA-binding function and the inflammatory phenotype not resolved\", \"Single-lab findings in ME49 strain only\", \"Whether the acute-stage effect is direct or a consequence of altered differentiation unclear\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"ME49\"}]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How BFD2 achieves selective recognition of its target transcripts and mechanistically integrates 3'-region binding with 5'-leader-driven cap-independent translation across its regulon remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of BFD2-RNA recognition\", \"Full target regulon and functional consequences per target uncharacterized\", \"Connection between 3' binding preference and translational activation unexplained\"],\n      \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 2, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0003729\", \"supporting_discovery_ids\": [0, 2], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0008270\", \"supporting_discovery_ids\": [0, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0045948\", \"supporting_discovery_ids\": [0, 2], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005737\", \"supporting_discovery_ids\": [0], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006417\", \"supporting_discovery_ids\": [0, 2, 3], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]},\n      {\"term_id\": \"GO:0030154\", \"supporting_discovery_ids\": [1, 4], \"attribution\": [{\"species\": \"Toxoplasma gondii\", \"strain\": \"\"}]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"BFD1 (transcriptional inducer of BFD2 and translational target via 5'-leader binding)\",\n      \"eIF1.2 (translation initiation factor acting upstream of BFD2)\",\n      \"eIF4E1 (cap-binding protein; dispensable for BFD2-driven cap-independent translation)\"\n    ],\n    \"other_free_text\": [\n      \"BFD2/ROCY1 forms a positive feedback loop with BFD1: BFD1 drives BFD2 transcription, BFD2 promotes BFD1 protein synthesis.\",\n      \"Binds hundreds of T. gondii transcripts with a preference for 3' regulatory regions; RNA-binding domains are essential for activity.\",\n      \"Drives cap-independent translation of BFD1 via direct binding to the BFD1 5'-leader.\",\n      \"ME49\\u0394bfd2 shows reduced proliferation and dampened host inflammatory cytokine induction during acute infection.\"\n    ]\n  },\n  \"strain_conflicts\": []\n}\n```","audit_flag":null,"strains":[{"strain":"ME49","gene_id":"TGME49_311100","name":"BFD2","product":"bradyzoite formation deficient protein BFD2","uniprot_acc":"A0A125YUW3","chromosome":"TGME49_chrXI","start_pos":1806848},{"strain":"GT1","gene_id":"TGGT1_311100","name":null,"product":"zinc finger (CCCH type) motif-containing protein","uniprot_acc":null,"chromosome":"TGGT1_chrXI","start_pos":1771325},{"strain":"RH88","gene_id":"TGRH88_050610","name":null,"product":"zinc finger (CCCH type) motif-containing protein","uniprot_acc":null,"chromosome":"CM023092","start_pos":1856971},{"strain":"VEG","gene_id":"TGVEG_311100","name":null,"product":"zinc finger (CCCH type) motif-containing protein","uniprot_acc":"B6K8I0","chromosome":"TGVEG_chrXI","start_pos":1819962}]}